Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series-Reference-Cited by-同舟云学术

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

Published:2021-09 Issue:9 Volume:174 Page:1330-1332
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Werbel William A.¹^ORCID,Boyarsky Brian J.¹^ORCID,Ou Michael T.¹^ORCID,Massie Allan B.¹^ORCID,Tobian Aaron A.R.¹,Garonzik-Wang Jacqueline M.¹,Segev Dorry L.¹^ORCID

Affiliation:

1. Johns Hopkins University School of Medicine, Baltimore, Maryland

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

The Ben-Dov Family

American Society of Transplantation

National Institute of Allergy and Infectious Diseases

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 312 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “REAl LIfe” observational study on the effectiveness of Evusheld prophylaxis against SARS-CoV-2 omicron variants in vaccine non-responder immunocompromised patients (REALISE);Vaccine;2024-10

2. Augmented humoral response to third and fourth dose of SARS-CoV-2 mRNA vaccines in lung transplant recipients;Respiratory Investigation;2024-09

3. Risk Factors for Impaired Cellular or Humoral Immunity after Three Doses of SARS-CoV-2 Vaccine in Healthy and Immunocompromised Individuals;Vaccines;2024-07-08

4. Inter- and intra-individual differences regarding SARS-CoV-2 and influenza vaccination in pediatric kidney transplant recipients: An observational study;Medicine;2024-07-05

5. Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial;The Lancet Rheumatology;2024-06